As the Federal Reserve prepares for a potential policy shift in 2026, analysts flag real estate, financials, energy, and consumer discretionary as vulnerable sectors. Structural challenges and changing macroeconomic conditions could pressure performance despite broader market gains.
Goldman Sachs CEO David Solomon, while optimistic on global markets, forecasts a deliberate deceleration in talent acquisition for 2026 as the bank sharpens its focus on operational efficiency and strategic resource allocation.
U.S. stock futures retreated Monday as investors parsed a mixed bag of global manufacturing data, raising fresh questions about the durability of corporate earnings against a backdrop of cooling factory activity in key European economies.
While a net cash position often signals financial resilience, it can also mask underlying weaknesses in growth and profitability. We examine three companies where ample cash on hand fails to translate into compelling investment cases, and explore what investors should look for instead.
The cryptocurrency market extended its losses on Monday, with the global market cap falling 2.9% to $2.65 trillion. Major assets like Bitcoin and Ethereum led the decline, while significant outflows from U.S. spot ETFs and shifting macroeconomic expectations fueled a wave of 'extreme fear' among investors.
Amidst recent market volatility driven by regional tensions, a closer look reveals companies with strong fundamentals demonstrating remarkable resilience and growth potential. We examine three such firms that are navigating the uncertainty and positioning themselves for the future.
As markets navigate a new year, analysts are eyeing potential outperformers. Amazon, BeOne Medicines, and Enterprise Products Partners emerge as compelling picks, each backed by distinct catalysts from AI to biotech breakthroughs.
Amidst the allure of high-growth tech narratives, Acsion (JSE:ACS) presents a case for steady, profitable growth. With strong insider alignment and improving margins, does this property-focused stock warrant a closer look from discerning investors?
As the pet care market expands, investors weigh the focused approach of Chewy against Walmart's diversified scale. While Chewy offers pure exposure, Walmart's broader ecosystem and advertising growth present a compelling alternative.
A dominant 78% institutional ownership stake in Domino's Pizza Group plc underscores the company's appeal to major financial players, while raising questions about stock volatility and long-term strategy.
Amid heightened regional tensions and a visible U.S. military buildup, Iran's Foreign Minister expresses cautious optimism for a nuclear deal, even as Tehran's supreme leader warns of a broader conflict should hostilities erupt.
Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.
After years of heavy investment in organic growth, midstream giant Enterprise Products Partners signals a strategic shift, slashing future capital expenditures and ramping up buybacks to return more cash to investors.
Meta CEO Mark Zuckerberg's forecast of a major AI infrastructure build-out through 2026 suggests continued robust spending on Nvidia's hardware, reinforcing the chipmaker's central role in the ongoing tech boom.
Spectrum Brands Holdings (SPB) has seen its share price swing between short-term gains and longer-term declines, raising questions about its true valuation. With a current price of $63.71 sitting below analyst targets, investors are weighing operational improvements against macroeconomic risks.
Danaher Corporation announces a strategic investment in Automata, aiming to integrate AI-ready automation systems with its extensive portfolio of instruments and reagents. The move signals a push to deliver comprehensive, data-driven lab solutions as the life sciences sector increasingly prioritizes efficiency and scalability.
McEwen Mining (NYSE: MUX) presents a complex picture for investors, with recent share price movements showing short-term declines against a backdrop of longer-term gains. As the market digests its latest financial results—$166.5 million in revenue alongside an $11.9 million net loss—questions arise about how to value its exposure to gold, silver, and copper. This analysis delves into the valuation metrics and market sentiment surrounding the miner.
In a significant move to bolster its healthcare services and retain staff, Walmart is creating thousands of new leadership positions and raising wages for pharmacy technicians across its U.S. stores.
Facing softer demand and tariff volatility, Minerals Technologies (MTX) reported steady 2025 sales of $2.1B but saw margins contract. Leadership emphasized cost discipline and safety while detailing a series of expansion projects poised to drive a meaningful rebound in the coming year.
Despite political pressure and vast reserves, U.S. oil majors ExxonMobil and Chevron are taking a cautious stance on new spending in Venezuela, demanding legal stability and fiscal reforms before committing fresh capital, even as they signal long-term interest.
